Last Price
0.68
Today's Change
+0.20 (41.66%)
Day's Change
0.655 - 0.76
Trading Volume
39,987,280
Currency: AUD AUD
Sector: Healthcare - Healthcare Healthcare - Healthcare
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.